Insider Shareholders with Direct Ownership of Point Biopharma Global Inc. (PNT)
This section provides a comprehensive overview of the insiders with direct ownership of Point Biopharma Global Inc. (PNT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
POINT Biopharma Global Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Allan C Silber
Executive Chairman |
4,268,605 | 0 | 4,268,605 $0 | 3 |
Nov 18, 2022
Added 0.52%
|
|
Joe A. Mccann
Chief Executive Officer |
3,616,313 | 2,160 | 3,616,313 $0 | 3 |
Nov 29, 2022
Added 0.06%
|
|
Neil E. Fleshner
Chief Medical Officer |
3,587,249 | 3,587,249 | 2,773,045 $0 | 4 |
Oct 31, 2023
Reduced 8.27%
|
|
Michael M. Gottlieb
Chief Commercial Officer |
1,156,887 | 0 | 1,156,887 $0 | 1 |
Jun 30, 2021
Added 50.0%
|
|
Jonathan R. Goodman
Director |
21,523 | 0 | 21,523 $0 | 1 |
Jun 30, 2021
Added 50.0%
|
|
David Charles Lubner
Director |
3,600 | 39,000 | 0 $0 | 3 |
Dec 27, 2023
Reduced 100.0%
|
|
Rajesh Malik
Director |
3,700 | 3,700 | 0 $0 | 2 |
Dec 26, 2023
Reduced 100.0%
|
| 0 | 17,161,278 | 0 $0 | 1 |
Dec 18, 2023
Reduced 100.0%
|
|
|
Gerald L. Hogue
Director |
21,596 | 21,596 | 0 $0 | 3 |
Dec 26, 2023
Reduced 100.0%
|
|
Yael Margolin
Director |
1,710 | 1,710 | 0 $0 | 2 |
Dec 27, 2023
Reduced 100.0%
|